Starting from predictive analytics introduced in 2017, we have continually expanded our AI capabilities. By 2020, we were leveraging Machine Learning for predictive analytics across all clinical research metrics, providing precise and comprehensive insights.
In 2023, we introduced “Ask AI” for clinical risk assessment and AI-augmented regulatory inspections, enabling targeted and efficient risk assessments and regulatory preparations.
In 2024, we launched AI-augmented clinical Due Diligence, further enhancing our suite of AI-driven solutions. This progress has been recognized with Microsoft Healthcare AI Certification in 2025, achieved after a rigorous independent audit, underscoring our commitment to ethical, validated AI in clinical trials.
